The Senate Health Committee approved a must-pass bill Wednesday to reauthorize funding for the Food and Drug Administration and change the agency’s regulatory processes.
Congress must send the FDA bill to President Obama by Oct. 1, and lawmakers are trying to avoid the type of eleventh-hour debate that entangled the last reauthorization.
Read the full story: http://hcp.lv/II8EK9
Soure: The Hill
Quadrivalent Influenza Vaccines Provide Higher Immunogenicity Against B Lineage vs Trivalent
December 5th 2023Overall, the study authors concluded that the immunogenicity of quadrivalent influenza vaccines (QIV) and trivalent inactivated influenza vaccines (TIV) was similar for common influenza ingredients for children ages 6 to 35 months.
Read More
Clinical Characteristics, Outcomes of Patients With Plaque Psoriasis on Tapinarof Cream
December 5th 2023Two posters presented at the 2023 Fall Clinical Dermatology Conference examined patient demographics, clinical characteristics, and outcomes in patients with plaque psoriasis treated with tapinerof cream.
Read More